How long before weight loss on Wegovy actually shows?

Why do most people not see results in week one?

This is probably the most common frustration our prescribers hear. You've started injecting, you feel a little queasy, and the scales haven't moved. That's entirely normal, and it's by design.

The starting dose of Wegovy (0.25mg) exists to let your body adjust to the medicine, not to drive weight loss. Nausea, bloating and changes in appetite are common at the beginning, and the lower starting dose reduces how severe those side effects tend to be. The NHS medicines page for semaglutide explains this clearly: the dose is increased gradually over several months, typically in four-week steps, reaching 2.4mg (the maintenance dose at which the clinical trials were run) after roughly 16 to 20 weeks.

For many people, appetite suppression becomes noticeable somewhere between weeks two and four. If you want a clearer sense of how long before you lose weight on Wegovy, our dedicated guide walks through what to realistically expect at each stage. Some people see nothing at all until they reach a higher dose step. Neither pattern is a sign that the medicine isn't working. It's worth keeping a simple weekly record rather than weighing daily; day-to-day fluctuations will mislead you.

At what point do the larger losses kick in?

The bulk of Wegovy's effect unfolds over months, not weeks. In the STEP 1 trial published in the New England Journal of Medicine, adults with obesity taking 2.4mg semaglutide alongside lifestyle changes lost an average of around 15% of body weight over 68 weeks. To put that in context: for someone starting at 100kg, that's roughly 15kg lost over about 16 months.

The losses are not linear. Many participants in that trial reported the most rapid change between months three and nine, once they'd been on the maintenance dose for a few weeks and their appetite was consistently lower. Progress often slows in the final months, which is normal as the body adapts. If you're curious about what Wegovy weight loss looks like before and after a full treatment course, there's a fuller breakdown elsewhere on the site.

The MHRA approved a higher 7.2mg dose in early 2026, with trial evidence suggesting average losses approaching 21% over 72 weeks, narrowing the gap with tirzepatide. That said, the new dose is approved for adults with a BMI of 30 or above, and whether it's appropriate is a clinical decision, not an automatic upgrade.

Does everyone lose weight at the same rate?

No, and this is worth being direct about. The 15% average from the STEP 1 trial is exactly that: an average across thousands of participants. Some people lost considerably more. Some lost less. A small number did not respond meaningfully at all.

The factors that influence your personal timeline include how consistently you've been able to reduce calorie intake, how much you've been able to increase activity, your starting BMI, and how far through titration you are. Sleep, stress and certain other medications also play a role. NICE's guidance on stopping treatment (summarised on the Wegovy overview page) notes that if there's been less than 5% weight loss after six months at the maintenance dose, continuing treatment should be reviewed with your prescriber.

Wegovy is a prescription medicine, not a substitute for a clinical relationship. A prescriber who can see your full picture (weight trends, dose history, any side effects) is better placed than any article to tell you whether your rate of change is on track. You can learn more about how the cost of private treatment fits into all this on our Wegovy cost page, which covers what a legitimate private prescription typically includes.

What should you expect in the first three months specifically?

Month one (0.25mg, then 0.5mg): appetite begins to shift; GI side effects (nausea, loose stools, burping) are most prominent early on and usually settle within days to a couple of weeks at each new dose step. Scale movement is modest if visible at all.

Month two (1mg): for many people, this is where reduced hunger becomes reliable rather than intermittent. Portion sizes naturally decrease. Weight loss becomes more consistent, often 0.5 to 1kg per week in this phase, though that varies widely.

Month three (1.7mg): appetite suppression is near its full effect for most people at this dose. Cumulative loss of 5 to 8% of starting weight is common by the end of this month, though some people are ahead or behind that range.

After the titration phase (once you've been on 2.4mg for several weeks) many people find the most sustained progress. Our guide covering how long before you see weight loss on Wegovy goes into more detail on what that sustained progress tends to look like, and is worth reading alongside our separate page on how weight loss on Wegovy tends to unfold across a full course, as well as the guidance on stopping. It's a question worth raising with your prescriber before you begin, not after.

If you'd like to discuss your own situation with a clinical team that reviews every case personally, you can start a free consultation with our prescribers today.